Skip to main content
Quest Diagnostics

Evaluation of Transport Media and Specimen Transport Conditions for the Detection of SARS-CoV-2 Using Real Time Reverse Transcription PCR

Evaluation of Transport Media and Specimen Transport Conditions for the Detection of SARS-CoV-2 Using Real Time Reverse Transcription PCR

Authors: Rogers AA, Baumann RE, Borillo GA, Kagan RM, Batterman HJ, Galdzicka M, Marlowe EM

Citation: J Clin Microbiol. 2020 Apr 27;JCM.00708-20. doi: 10.1128/JCM.00708-20. [Epub ahead of print]

Specialties: COVID-19, Infectious Disease

Download key summary

Related content

Publication
Comparison of SARS-CoV-2 RT-PCR Ct values across multiple assays with different targets
Audio Podcast
Alternative Specimen Collection Options
Publication
SARS-CoV-2 Spike-Protein Targeted Serology Test Results and Their Association With Subsequent COVID-19-Related Outcomes
Test FAQ
SARS CoV 2 Antibody Testing
Publication
Assessing vulnerability to COVID 19 in high risk populations: the role of SARS CoV 2 spike targeted serology
Publication
Estimated SARS-CoV-2 antibody seroprevalence trends and relationship to reported case prevalence from a repeated, cross-sectional study in the 50 states and the District of Columbia, United States-October 25, 2020-February 26, 2022

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.